Prostate cancer is the most common cancer among men in the United States, which is why screening, a major focus of Prostate Cancer Awareness Month in September, is so important. <\/p>\n
It can also be silent. Most men diagnosed with prostate cancer have no symptoms at all, Dr. William Dahut, chief scientific officer for the American Cancer Society, tells TODAY.com. <\/p>\n
The first sign is usually an elevated prostate-specific antigen (PSA) test, then the cancer is confirmed through imaging and a biopsy. <\/p>\n
Treatment can be very effective, but it\u2019s not always the right next step. For men who are diagnosed with very early, slow-growing prostate cancer, \u201cyou have options,\u201d says Dahut. <\/p>\n
Men\u2019s Health Tip of the Day: When to Try \u2018Active Surveillance\u2019 for Prostate Cancer<\/p>\n
After a cancer diagnosis, it\u2019s natural to want to jump to treatment, but for low-risk prostate cancers (about 14% of new diagnoses)<\/a>, an approach called active surveillance is usually more appropriate, Dahut says.<\/p>\n Active surveillance<\/a> involves delaying immediate treatment and instead closely monitoring slow-growing prostate cancer, with a plan to start therapy if tests show it\u2019s growing, Dahut explains.<\/p>\n This includes routine doctor\u2019s visits, PSA tests every six months, annual rectal exams, plus imaging and biopsies, per the ACS.<\/p>\n Prostate cancer is graded using a Gleason score. \u201cGleason grade 1, or the earliest stage, those patients are not immediately at risk of having progression of their cancer,\u201d says Dahut.<\/p>\n In these cases, tumor is localized and slow-growing, making it low-risk. \u201cThese patients can be safely monitored, and oftentimes go years and years without any therapy ever needed,\u201d Dahut says. <\/p>\n If active surveillance reveals any warning signs, patients can start therapy immediately. <\/p>\n \u201cSometimes we see it changing relatively quickly, but almost always we have time to intervene prior to symptoms or putting patients at any real risk,\u201d says Dahut.<\/p>\n (Active surveillance is different from another approach known as \u201cwatchful waiting,\u201d which involves delaying treatment and relies on monitoring for symptoms, instead of routine visits or tests. This is best suited for older patients or those with chronic conditions. \u201cIt\u2019s an important distinction,\u201d says Dahut.)<\/p>\n Why It Matters<\/p>\n \u201cThe reason you treat early-stage prostate cancer is to prevent complications from the cancer,\u201d Dahut explains. <\/p>\n Treatment involves surgery, radiation and other therapies \u2014 which can cause side effects like incontinence, impotence and rectal bleeding, Dahut says. <\/p>\n \u201cIf the patient has no symptoms, any therapy would make them feel much worse,\u201d says Dahut. It may disrupt urinary, bowel and sexual function for years, per the Prostate Cancer Foundation<\/a>.<\/p>\n That\u2019s why waiting to start treatment may be a better option to preserve quality of life for men with early, low-risk cancer.<\/p>\n \u201cIf you know you have a window in which you can safely delay or defer therapy, you can go years (without) the side effects of treatment, but still have the potential benefits of preventing complications down the road,\u201d Dahut explains.<\/p>\n After routine PSA screening was implemented in the 1990s, Dahut says prostate cancer diagnoses soared and so did \u201cover-treatment\u201d of early stage patients with aggressive treatments.<\/p>\n \u201cWe\u2019ve gotten better at determining who can do active surveillance and who needs more urgent therapy,\u201d says Dahut.<\/p>\n It\u2019s important to note that active therapy isn\u2019t doing nothing. And if treatment is the destination, \u201cyou can safely stop at multiple places along the way,\u201d says Dahut.<\/p>\n How to Get Started<\/p>\n Average-risk men should talk to their doctor about starting PSA screenings at age 50, per the ACS<\/a>. Higher-risk individuals may need to consider starting screening as early as age 40.<\/p>\n If you\u2019re diagnosed with early stage, low-risk prostate cancer, talk to your doctor about your options and what\u2019s best for you.<\/p>\n Although prostate cancer often has no warning signs, it\u2019s important to watch for any symptoms<\/a>.<\/p>\n